학술논문
Stereotactic Ablative Radiotherapy for oligo-progressive disease refractory to systemic therapy in Non-Small Cell Lung Cancer: A registry-based phase II randomized trial (SUPPRESS-NSCLC)
Document Type
Article
Author
Source
In Clinical and Translational Radiation Oncology March 2022 33:115-119
Subject
Language
ISSN
2405-6308